AGRI BIO SCIENCES INC
10QSB, 2000-08-18
MISCELLANEOUS BUSINESS CREDIT INSTITUTION
Previous: AURORA FOODS INC /DE/, 8-K, EX-99.1, 2000-08-18
Next: AGRI BIO SCIENCES INC, 10QSB, EX-27, 2000-08-18



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X]               Quarterly   report   pursuant   to  Section  13  or  15(d)  of
                  the   Securities   Exchange   Act of  1934: For  the quarterly
                  period ended: June 30, 2000

[  ]              Transition  report  pursuant  to  Section  13 or  15(d) of the
                  Securities  Exchange  Act of 1934 For the  transition period
                  from _______ to _________

                                          Commission file number: 000-25557

                             AGRI BIO-SCIENCES, INC.
        (Exact name of small business issuer as specified in its charter)

                  Delaware                                     76-0481583
       (State or other jurisdiction of                      (I.R.S. Employer
       incorporation or organization                       Identification No.)

       9230 Keogh Road, Houston, Texas                     77040
      (Address of principal executive officer)            (Zip Code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No ___

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE
PRECEDING FIVE YEARS

Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court Yes ___ No ___

APPLICABLE ONLY TO CORPORATE ISSUERS

         The number of shares of common stock, $0.001 par value, outstanding as
June 30, 2000: 11,141,619 shares

Transitional Small Business Disclosure Format (check one):   Yes ___   No  X
                                                                          --


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                           PERIOD ENDED JUNE 30, 2000

                                      INDEX

<TABLE>
<CAPTION>
PART I.  FINANCIAL INFORMATION                                                                                 Page

         Item 1.  Financial Statements

         Condensed financial statements of Agri Bio-Sciences, Inc.:

<S>                                                                                                              <C>
                  Balance sheet as of June 30, 2000                                                               3

                  Income  statements for the three and six months ended June 30,
                    2000, three months and six months ended June 30, 1999 and
                    period from May 30, 1995 (Date of Inception) to June 30, 2000                                 4

                  Statements  of cash  flows for the six  months  ended June 30,
                    2000, the six months ended June 30, 1999 and period
                    from May 30, 1995 (Date of Inception) to June 30, 2000                                        5

                  Notes to financial statements                                                                   6

         Item 2.  Plan of Operations                                                                              7

PART II. OTHER INFORMATION

         Item 6.  Exhibits and Reports on Form 8-K                                                               10

                  (a)      Exhibits

SIGNATURE                                                                                                        11

</TABLE>

<PAGE>


PART I.   FINANCIAL INFORMATION

Item 1.   Financial Statements

                             AGRI BIO-SCIENCES, INC ............
                          (A Development Stage Company)
                                  Balance Sheet
                                  June 30, 2000

ASSETS
     Cash$ .....................................................      $   9,059

     Fertilizer plant and equipment, net .......................        160,636
                                                                      ---------


         TOTAL ASSETS ..........................................      $ 169,695
                                                                      =========




LIABILITIES

     Accounts payable ..........................................      $   1,562
     Accrued expenses ..........................................         20,225
     Due to current stockholders ...............................        168,000
     Due to former stockholder .................................        100,000
                                                                      ---------


         TOTAL LIABILITIES .....................................        289,787
                                                                      ---------


STOCKHOLDERS' EQUITY
     Common stock, $.001 par value, 20,000,000
         shares authorized, 11,000,000 issued
         and outstanding .......................................         11,000
     Paid in capital ...........................................        617,150
     Deficit accumulated during the development stage ..........       (748,242)
                                                                      ---------

     TOTAL STOCKHOLDERS' EQUITY (DEFICIT) ......................       (120,092)
                                                                      ---------

     TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY ................      $ 169,695
                                                                      =========



<PAGE>


                             AGRI BIO-SCIENCES, INC ..........
                          (A Development Stage Company)
                             Statements of Expenses
                      6 Months Ended June 30, 2000 and 1999
                  and the period from May 30, 1995 (Inception)
                              Through June 30, 2000

<TABLE>
<CAPTION>
                                                          2000         - - 2000        - - 1999        - - 1999       May 30,1995
                                                        3 Months        6 months        3 Months        6 Months      (Inception)
                                                          Ended          Ended           Ended           Ended         to June 30,
                                                          June 30        June 30         June 30         June 30           2000
                                                       ------------    ------------    ------------    ------------    ------------


EXPENSES
<S>                                                       <C>            <C>               <C>           <C>                  <C>
     Fees paid for services
       by stockholders ..............................                                                                   $    188,400
     Other administrative ...........................   $      1,448    $     17,159    $     11,055    $     43,667         379,647
     Inventory writedown ............................                                                                        100,000
     Interest .......................................          7,210          11,172                                          66,945
     Depreciation ...................................          1,250           2,500           1,250           2,500          13,250
                                                        ------------    ------------    ------------    ------------    ------------

         Net (loss) .................................   $     (9,908)   $    (30,831)   $    (12,305)   $    (46,167)   $  (748,242)
                                                          ============    ============    ============    ============    ==========


(Loss) per common share .............................   $      (.001)   $      (.003)   $      (.001)   $      (.004)
Weighted average
     shares outstanding .............................     11,000,000      11,000,000      10,900,000      10,900,000
</TABLE>


<PAGE>

<TABLE>
<CAPTION>

                             AGRI BIO-SCIENCES, INC
                          (A Development Stage Company)
                            Statements of Cash Flows
                      6 Months Ended June 30, 2000 and 1999
                  and the period from May 30, 1995 (Inception)
                              Through June 30, 2000

                                                                                                                      Inception
                                                                                                                       Through
                                                                                               2000         1999         2000
                                                                                              ---------    ---------    ---------
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                                            <C>          <C>          <C>
     Net (loss) ............................................................................   $ (30,831)   $ (46,167)   $(748,242)
     Adjustments to reconcile net income
         to net cash provided by operating activities
       Depreciation ........................................................................       2,500        2,500       13,250
       Common stock issued for services ....................................................                                87,650
       Writedown of inventory value ........................................................                               100,000
       Contribution of imputed interest ....................................................       5,000                    42,500
       Common stock issued for equipment ...................................................                                 2,500
     Changes in:
       Accounts payable ....................................................................     (13,738)      19,014        1,562
       Accrued expenses ....................................................................       9,449        1,500       20,225
                                                                                               ---------    ---------    ---------
       NET CASH USED BY
                  OPERATING ACTIVITIES .....................................................     (27,620)     (23,153)    (480,555)
                                                                                               ---------    ---------    ---------

CASH FLOWS FROM INVESTING ACTIVITIES
     Plant site construction and equipment purchases .......................................                               (73,886)

CASH FLOWS FROM FINANCING ACTIVITIES
     Sales of common stock for cash ........................................................                               895,500
     Purchase of stock from a former shareholder ...........................................                              (500,000)
     Advances by shareholders ..............................................................     20,000       12,000       168,000
                                                                                              ---------    ---------    ---------
       NET CASH PROVIDED BY
                  FINANCING ACTIVITIES .....................................................     20,000       12,000      563,500
                                                                                              ---------    ---------    ---------

NET INCREASE (DECREASE) IN CASH ............................................................     (7,620)     (11,153)       9,059

CASH - Beginning ..........................................................................      16,679       11,989
                                                                                               ---------    ---------     --------
     - End of period ......................................................................   $   9,059    $     836    $   9,059
                                                                                                =========    =========    =========

SUPPLEMENTAL DISCLOSURES
     Non-cash investing and financing activities:

       Contribution of plant site at inception .............................................                           $ 100,000
       Purchase of bagged fertilizer for note payable ......................................                             100,000
</TABLE>


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                          NOTES TO FINANCIAL STATEMENTS

NOTE 1 - BASIS OF PRESENTATION

The accompanying  unaudited interim financial  statements of Agri  Bio-Sciences,
Inc.  have been  prepared  in  accordance  with  generally  accepted  accounting
principles  and  should  be read  in  conjunction  with  the  audited  financial
statements  and notes thereto  contained in the  Company's  latest Annual Report
filed  with  the  SEC  on  Form  10-KSB.  In  the  opinion  of  management,  all
adjustments,  consisting of normal recurring  adjustments,  necessary for a fair
presentation of financial position and the results of operations for the interim
periods  presented  have been  reflected  herein.  The results of operations for
interim periods are not necessarily indicative of the results to be expected for
the full year.  Notes to the  financial  statements  which  would  substantially
duplicate the disclosure  contained in the audited financial  statements for the
most recent fiscal year, 1999, as reported in the 10-KSB, have been omitted.


<PAGE>


PLAN OF OPERATION

         Agri Bio-Sciences,  Inc., a Delaware corporation (the "Company"),  is a
developmental  stage company formed for the production of a fertilizer  known as
"Micro Min." It has not yet commenced full-scale  production  activities and has
not  generated  any  revenues  from  operations.  The  Company  had  begun  very
preliminary  efforts to procure an initial market maker for the Company's Common
Stock, par value $.001 per share ("Common Stock"), so that public trading in the
Common Stock could commence in the United States. Because of the Company's close
connection to the country of Mexico, the Company has suspended these efforts for
the present.  However,  the Company is now seeking to establish a trading market
for the Common Stock in Mexico.  In this  connection,  the Company has engage an
attorney and is in  discussions  with a stockbroker  (both located in Mexico) to
assist in this effort.

EXCLUSIVE SALE AND PURCHASE ARRANGEMENT:

         The Company was formed  solely for the purpose of  manufacturing  Micro
Min and does not  intend  to  engage  in the sale and  marketing  of Micro  Min.
Instead, Global Farm Sciences, Inc., a Texas corporation ("Global"),  was formed
in  December  1997 by Lester  Stephens,  M. Manny  Kalish and  Patrick N. Morgan
(founders and board members of the Company) for the purpose of selling Micro Min
to  foreign  entities.  On August  27,  1998,  the  Company  signed a  five-year
exclusive product sales agreement with Global. This Agreement requires Global to
purchase  2,000  metric  tons of Micro  Min  during  the year  1999 and 2000 and
thereafter  purchase 3,000 metric tons of Micro Min during each succeeding year.
Global  must pay  $620.00  per  metric  ton in United  States  dollars,  FOB the
Company's plant facility in Bay Springs,  Mississippi.  Global must remit 50% of
the  purchase  price with each  purchase  order for Micro Min  forwarded  to the
Company.  (This  initial  amount  provides  the Company with  adequate  funds to
produce  one metric ton of product  and thereby  provides  the Company  with the
necessary funds to keep the plant in operation).  Thereafter,  Global must remit
the remaining 50% payment of its purchase  order to the Company within ninety 90
days of its receipt of the product FOB the plant.  The Global  agreement  may be
terminated prior to its five-year term upon the occurrence of certain  customary
termination  events,  such as breach of contract or  bankruptcy.  Global did not
purchase  the required  2,000  metric tons of Micro Min in 1999.  The Company is
currently  forebearing  from any action against Global on the belief that Global
will be able to remedy in the  future  its  failure  to  purchase  the  required
amount.

         During the quarter  ended  September  30, 1999,  the Company and Global
realized that the success of Global's business  activities in Mexico was limited
due to Global's  status as a foreign  corporation in that country.  Accordingly,
with the knowledge and consent of the Company, Global has been employing Ciences
Agro  Ambientales,  S.A.  de C.V.  ("CIAGAM")  to  undertake  the  sales-related
activities that Global was originally to undertake.  CIAGAM is indirectly  owned
by certain  members of the  Company's  Board of  Directors,  and is a registered
Mexican  corporation  fully authorized under Mexican corporate law. Global's use
of CIAGAM for sales-related  activities is expected for the foreseeable  future.
While there had been  discussions  of a formal  assignment to CIAGAM of Global's
rights and  obligations  under its exclusive  product sales  agreement  with the
Company, such an assignment is not presently expected.

STATUS OF SALES EFFORTS:

         For  some  time,  Global  had been  holding  discussions  with  various
governmental,  quasi--governmental  and industry parties, who would serve as the
primary  distributor  of  Micro  Min in  Mexico.  These  parties  have  included
Fertilizantes  Nacionales,  S.A. de C.V., the Mexican federal and state Colleges
of Agricultural  Engineers,  and INTAGRO, a company based in Veracruz,  Mexican.
These discussions failed to produce a definitive agreement. Because of the delay
in  establishing  a formal  relationship  with any  large  sales  force,  CIAGAM
(assuming the role previously  undertaken by Global) has been making sales calls
on  critical  governmental  and  quasi-governmental  agencies as well as private
businesses.  CIAGAM has reached an  agreement in principle  with  AGROFERMEX,  a
Mexican  fertilizer  distributor  having  250  offices,  regarding  AGROFERMEX's
serving as a non-exclusive distributor of Micro Min in Mexico. This agreement in
principle  has not yet produced a definitive,  legally  binding  agreement,  and
whether or not a definitive,  legally binding agreement will be executed can not
now be determined.

         Moreover, the Company is also working with approximately 800 farmers in
the  state  of  Guanajuato,  Mexico  who  have  indicated  a  desire  to  form a
co-operative  and have the Company install a laboratory on their behalf.  On the
average,  each of these farmers has approximately  700 hectares,  for a total of
approximately  560,000  hectares or  approximately  1,400,000 acres. At a bag of
Micro  Min per  acre,  approximately  14,000  metric  tons of Micro Min would be
required  to serve the  co-operative.  At a profit of $305 per metric  ton,  the
Company  would  realize an aggregate  profit of  approximately  $4,270,000.  The
Company  expects that an  affiliated  entity will  establish,  own and operate a
laboratory  for the  benefit  of the  co-operative.  This  project  is in a very
preliminary  stage, and there can be no assurance that this project will ever be
completed in the scope currently being contemplated, if at all.

BANK FINANCING SALES:

         CIAGAM  has  recently  established  a  relationship  with the  Banco de
Mexico,  the national bank of Mexico. The Banco de Mexico has indicated a desire
to establish a credit line  sufficient for Mexican  farmers to purchase  certain
items of agriculture  necessary for growing crops. Although CIAGAM and the Banco
de Mexico have not agreed upon  definitive  terms nor  entered  into  definitive
agreements  regarding  the line of credit,  current  discussions  are  revolving
around  certain  terms.  First,  the line of credit is  expected to have a total
amount ranging from $425,000 to $1.2 million. This amount of funding is expected
to service  adequately  an  eight-state  targeted  area in Mexico.  In addition,
amounts  advanced  on the line of  credit  to  farmers  will be due and  payable
approximately 90 days after the advance.  Moreover, as is customary, the line of
credit  would  require the  farmers to place  their land in trust as  collateral
against  the  amounts  advanced.  Finally,  CIAGAM is expected to be required to
guarantee a  comparatively  small portion of each advance on the line of credit.
Despite the current  status of the  negotiations  regarding  the line of credit,
there  can  be  no  assurance  that  CIAGAM  will  successfully   conclude  such
negotiations  and  establish  a line of  credit  with the Banco de Mexico or any
other lender.

LABORATORY OPERATION:

         At one point, the Company intended to forego the actual  establishment,
ownership  and  operations  of  laboratories  and instead  license the Company's
software to Intertek  Testing  Services,  a prominent  international  laboratory
testing company ("ITS"), for use in ITS's existing and future laboratories.  The
Company and ITS never  reached a definitive  agreement  in this regard.  Now the
Company plans to license its software to CIAGAM,  which will be responsible  for
the actual establishment,  ownership and operations of the laboratories.  CIAGAM
expects  to  install  its  first  laboratory  by  the  end  of  September  2000.
Originally,  CIAGAM had expected to have installed its first  laboratory by now.
However, deliberations regarding the best location for the first laboratory have
delayed  installation.  CIAGAM has available funds in the amount of $150,000 for
this purpose and expects to raise an additional  $250,000.  While  management of
CIAGAM is  confident  that it will raise the $250,000  additional  amount in the
immediate  future,  there can be no assurance in this regard.  CIAGAM originally
expected  to  locate  the  first  laboratory  in a  double-wide,  pre-fabricated
building  on the  outskirts  of Mexico  City to service  farmers in the state of
Morelos.  However,  two  farmers'  unions  located in the state of Sinaloa  have
approached  CIAGAM with a view of having CIAGAM  locate the first  laboratory in
Sinaloa to service  farmers in Sinaloa.  These  farmers'  unions have offered to
provide a building for housing the first  laboratory.  CIAGAM  expects to make a
decision  on the  location  of its first  laboratory  in the  immediate  future.
Regardless of where the first  laboratory is located and whom it services,  this
laboratory  will  receive  soil  samples  and process  them using the  Company's
computer  copyrighted  software to complete  analytical  reports that depict the
present  condition of the farmers'  soil.  The reports will also  recommend  the
exact  fertilizers  to be used  both in kind and  amounts  on a per acre  basis.
Management  believes that a service like this has never before  available to the
farmers of Mexico.  Once the first laboratory  achieves  acceptable  performance
levels,  CIAGAM  expects to establish  additional  laboratories,  eventually  to
service all of Mexico.

CORPORATE FUTURE GOALS:

         The Company  (through  CIAGAM)  intends to continue to pursue  sales of
Micro Min in Mexico and possibly  complete broad product sales  agreements  with
AGROFERMEX  or some  other  firm or  organization  having a large  sales  force.
Although the Company  will be involved in the  establishment  of CIAGAM's  first
laboratory  only to the extent of the licensing of the Company's  software,  the
Company  expects that the  installation  of this laboratory will greatly further
the Company's business.

CAPITAL REQUIREMENTS, RESEARCH AND DEVELOPMENT AND EQUIPMENT EXPENDITURES:

         The Company does not believe that it will need any  financing  over the
next 12 months. Management believes that the Company will be able to finance its
operations  through  its  receipt of down  payments  in the amount of 50% of the
purchase price of each purchase  order issued by Global.  Such down payments are
expected to cover all direct costs of producing the related product. The Company
has only minimal  overhead,  which has thus far been  financed  through  amounts
advanced by certain  directors of the Company.  These  directors  have indicated
that they intend to continue to provide limited financing of overhead,  but they
are under no legal obligation to do so and may cease at any time.

         Moreover,  the Company does not intend to conduct any further  research
and  development  over the next 12 months.  However,  if CIAGAM  meets its sales
expectations,  the  Company  expects  to add  (during  the  next  12  months)  a
California  Pellet Mill pelletizer and sufficient  additional  employees to meet
the demand for additional production.

ADDITIONAL INFORMATION:

         On June 12,  2000,  Lester H.  Stephens  resigned as  President  of the
Company to focus his business  attentions  on Tex-Mex  Capital,  Inc., a company
controlled  by certain  directors of the Company.  The Board of Directors of the
Company has elected  Robert Lane as President to succeed Mr.  Stephens.  For the
past five  years,  Mr.  Lane has owned Bob Lane &  Associates,  a  Houston-based
manufacturers  representative  company.  Since July 1998,  he has also served as
managing  partner of Creative  Communications,  a  Houston-based  distributor of
packaging, printing and promotions.

PART II. OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

                  (a)      The following exhibits are filed with this Quarterly
Report or are incorporated herein by reference:

                  Exhibit

                  Number                    Description

                   27                       Financial Data Schedule

                  (b)      Reports on Form 8-K

                           None


<PAGE>


                                    SIGNATURE

         In accordance with the requirements of the Exchange Act, the Registrant
has duly  caused  this  Report to be signed  on its  behalf by the  undersigned,
thereunto duly authorized.

                                   AGRI BIO-SCIENCES, INC.
                                  (Registrant)

                                   By: /s/Robert Lane
                                   Robert Lane,
                                   President
                                   (Principal Executive Officer, Principal
                                   Financial Officer and Principal Accounting
                                   Officer)

Dated: August 17, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission